Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

*Product:*	Opdivo
Active Ingredient:	Nivolumab 47mg equivalent to 40mg/4mL
Dosage Form:	Concentrate for infusion
New Zealand Sponsor:	Bristol-Myers Squibb (NZ) Limited
Manufacturer:	Bristol-Myers Squibb Holdings Pharma Limited, Manati, Puerto Rico
Note: The application received 23 October 2018 is for extension of indications.

*Product:*	Opdivo
Active Ingredient:	Nivolumab 107mg equivalent to 100mg/10mL
Dosage Form:	Concentrate for infusion
New Zealand Sponsor:	Bristol-Myers Squibb (NZ) Limited
Manufacturer:	Bristol-Myers Squibb Holdings Pharma Limited, Manati, Puerto Rico
Note: The application received 23 October 2018 is for extension of indications.

*Product:*	Opdivo
Active Ingredient:	Nivolumab 47mg equivalent to 40mg/4mL
Dosage Form:	Concentrate for infusion
New Zealand Sponsor:	Bristol-Myers Squibb (NZ) Limited
Manufacturer:	Bristol-Myers Squibb Holdings Pharma Limited, Manati, Puerto Rico
Note: The application received 4 February 2019 is to register an additional dose regimen.

*Product:*	Opdivo
Active Ingredient:	Nivolumab 107mg equivalent to 100mg/10mL
Dosage Form:	Concentrate for infusion
New Zealand Sponsor:	Bristol-Myers Squibb (NZ) Limited
Manufacturer:	Bristol-Myers Squibb Holdings Pharma Limited, Manati, Puerto Rico
Note: The application received 4 February 2019 is to register an additional dose regimen.

Dated this 26th day of August 2019.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule